Charleston, SC -- (SBWIRE) -- 09/11/2013 -- Today’s Penny Stocks wants you, the investor, to have the ability to be informed in your trading decisions. Our website is designed to take you to the information you need to be at the top of your game in trading penny stocks. Today’s Penny Stocks issues news updates on the following stock: First Bancorp (NYSE:FBP), PowerShares WilderHill Clean Energy (ETF) (NYSEARCA:PBW), Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC), Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY).
First Bancorp (NYSE:FBP) opened its last trade at the price of $6.55. Its closing price was $6.56 after gaining 0.61% for the day. The company traded with the total volume of 1,141,218 shares, while its average trading volume remained 1.56 million shares. The beta of this stock stands at 1.84. First BanCorp., operates as the bank holding company for FirstBank Puerto Rico that provides a range of financial products and services to retail, commercial, and institutional clients.
For How Long FBP will Fight for Profitability? Read This Trend Analysis report
PowerShares WilderHill Clean Energy (ETF) (NYSEARCA:PBW) percentage change surged 1.53% to close at $5.99 with the total traded volume of 1,122,250 shares. The 52 week range of the stock remained $3.46 - $6.05, while its day lowest price was $5.95. The share price hit the day highest price of $6.03. PowerShares Wilderhill Clean Energy Portfolio (the Fund) seeks investment that corresponds to the price and yield of the WilderHill Clean Energy Index (the Index). The Fund will invest at least 90% of its total assets in common stocks that comprise the Index.
For How Long PBW’s Gloss will Attract Investors? Find out via this report
Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) traded on volume of 1,113,085 shares in the last session against average volume of 213,272.00 shares. The company started its trading session with the price of $3.54 and closed at $3.67 by scoring +8.26%. Cyclacel Pharmaceuticals, Inc., a development-stage biopharmaceutical company, engages in the development and commercialization of mechanism-targeted drugs to treat human cancers and other serious diseases.
Will CYCC Continue To Move Higher? Find Out Here
Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY) started its last trading session with the price of $3.03 and closed at $2.84 by scoring -5.02%. The stock traded with total volume of 1,107,877 shares, while the average trading volume remained 359,537.00 shares. The beta value of this stock stands at 1.41. Day range for the stock was $2.80 - $3.07. Oncolytics Biotech Inc., a development stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancers. The company develops REOLYSIN, a therapeutic reovirus that is in various clinical trials for use as human cancer therapeutic.
Will ONCY Get Buyers Even After The Recent Rally? Find Out Here
About Today’s Penny Stocks:
Today’s Penny Stocks wants you, the investor, to have the ability to be informed in your trading decisions. Our website is designed to take you to the information you need to be at the top of your game in trading penny stocks. Today’s wants you to do your own due diligence on your investments please use our site to find the information you need on whichever investment you choose.
The disclaimer is to be read and fully understood before using our site, or joining our newsletter email list. Never invest into a stock discussed on this web site or the TodaysPennyStocks.com newsletter unless you can afford to lose your entire investment.
Please consult with a certified financial advisor before making any investment decisions.
TodaysPennyStocks.com is owned and operated by FlipVentures LLC. We are engaged in the business of advertising and promoting companies for monetary compensation. All content in our releases is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Read Full Disclaimer at: http://todayspennystocks.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)